journal
Journals Global Cardiology Science & Pr...

Global Cardiology Science & Practice

https://read.qxmd.com/read/37575290/dipyridamole-induced-stemi-case-report-and-review-of-the-literature
#21
Hussam Al Hennawi, Sunita Lakhani, Shayan Iqbal Khan, Sarin Atam, Usama Sadiq, Joseph Rigotti, Abhinav Nair
Dipyridamole nuclear myocardial perfusion imaging is a safe and useful modality for assessing myocardial ischemia. It is the modality of choice for cardiac risk stratification in patients who are unable to exercise. Intravenous dipyridamole causes coronary vasodilation and may result in heterogeneity of coronary blood flow in significant coronary artery disease. Ischemic electrocardiographic changes following pharmacological stress testing are less likely to occur compared with exercise stress tests. Ischemia is more likely to be present in the form of ST depression, with ST-segment elevation being exceedingly rare...
August 1, 2023: Global Cardiology Science & Practice
https://read.qxmd.com/read/37575289/predictors-of-protein-losing-enteropathy-after-fontan-completion-an-8-year-retrospective-study-at-sheikh-khalifa-medical-city
#22
JOURNAL ARTICLE
Antoine Fakhry AbdelMassih, Laszlo Kiraly, Hazem El Badaoui, Mohammad Khan, Balazs Hetharsi, Judit Noemi Till, Aleksandr Y Omelchenko, Alaa Ziad Salah, Farah Tarik Al Jburi, Laila Alkhouli, Mina Taher, Najah Alhosani, Omnia Youssef, Sumaiya Iqbal, Zahraa Allami, Neerod Kumar Jha, Eman Mahmoud Hamad, Yasmin Omar, Arshad Khan, Zafar Azeez, Michael Attia, Mariam Mina, Alyaa Al Ali, Yara Khaled Afifi, Meryam El Shershaby, Afnan Musleh
BACKGROUND: The Fontan procedure is the final stage of a three-stage palliation process in patients born with a univentricular heart as part of hypoplastic left heart syndrome (HLHS) or other pathologies with a univentricular heart. As essential as this procedure has proven to be for such cases, the Fontan physiology diminishes cardiac output and expands systemic venous pressure, which then leads to venous congestion that can be complicated by protein-losing enteropathy (PLE). This retrospective study aimed to identify the predictors of such complications in all patients who underwent completion of the Fontan procedure at our center (Sheikh Khalifa Medical City/SKMC) in the past eight years...
August 1, 2023: Global Cardiology Science & Practice
https://read.qxmd.com/read/37575288/deliver-extending-the-benefits-of-sglt-2-inhibitors
#23
JOURNAL ARTICLE
Kerollos Samaan, Kerolos Wagdy
The DELIVER trial investigated the efficacy and safety of dapagliflozin in patients with heart failure and preserved or mildly reduced ejection fraction. The trial demonstrated that dapagliflozin significantly reduced the risk of worsening heart failure or cardiovascular death compared to placebo. The benefit was mainly driven by a decrease in heart failure hospitalizations, with no significant impact on mortality. Patients with different ejection fractions and diabetes status showed similar treatment effects...
August 1, 2023: Global Cardiology Science & Practice
https://read.qxmd.com/read/37575287/systemic-lupus-erythematous-associated-with-multi-vessel-spontaneous-coronary-artery-dissection
#24
Dilesha D Kumanayaka, Ilsen Hernandez, Asrar Ahmad, Addi Suleiman
Spontaneous coronary artery dissection (SCAD) is a rare cause of acute coronary syndrome (ACS), often associated with atherosclerosis. However, SCAD has been increasingly recognized as a distinct entity, especially in young females without traditional cardiovascular risk factors. We present a case of a 56-year-old female with systemic lupus erythematosus (SLE) who developed multivessel SCAD involving the right coronary artery (RCA) and ramus. The patient's clinical presentation included typical chest pain, elevated troponins, and ST depressions on electrocardiography...
August 1, 2023: Global Cardiology Science & Practice
https://read.qxmd.com/read/37575286/a-rare-case-of-unilateral-agenesis-of-left-pulmonary-artery-presenting-as-severe-pulmonary-arterial-hypertension
#25
Susheel Kumar Malani, Prashant Kashyap, Digvijay Nalawade
A 26-year-old young male patient presented with progressive dyspnea over the previous 2 years. The patient also had pulmonary hypertension. Computed tomography (CT) pulmonary angiography showed absence of the left pulmonary artery, and conventional pulmonary and aortic root angiograms showed ipsilateral lung receiving collaterals from the left internal mammary artery and thyrocervical trunk.
August 1, 2023: Global Cardiology Science & Practice
https://read.qxmd.com/read/37575285/a-cross-sectional-study-of-echocardiographic-characteristics-of-patients-diagnosed-with-sars-cov-2-delta-strain
#26
JOURNAL ARTICLE
Amit Varshney, Ramakant Rawat
BACKGROUND: The delta variant of SARS-CoV-2 has been associated with increased mortality and multi-organ failure, affecting various systems in the body. Cardiovascular manifestations including arrhythmias, heart failure, myocarditis, myocardial damage, and thromboembolism are commonly observed in patients infected with the delta variant. MATERIALS AND METHODS: This study enrolled 106 individuals who tested positive for the delta strain of SARS-CoV-2 using real-time RT-PCR between May 25, 2020, and October 15, 2021...
August 1, 2023: Global Cardiology Science & Practice
https://read.qxmd.com/read/37575284/pulmonary-circulatory-and-renal-considerations-in-the-early-postoperative-management-of-the-lung-transplant-recipient
#27
REVIEW
Reda E Girgis, Ryan J Hadley, Edward T Murphy
Lung transplantation volumes and survival rates continue to increase worldwide. Primary graft dysfunction (PGD) and acute kidney injury (AKI) are common early postoperative complications that significantly affect short-term mortality and long-term outcomes. These conditions share overlapping risk factors and are driven, in part, by circulatory derangements. The prevalence of severe PGD is up to 20% and is the leading cause of early death. Patients with pulmonary hypertension are at a higher risk. Prevention and management are based on principles learned from acute lung injury of other causes...
August 1, 2023: Global Cardiology Science & Practice
https://read.qxmd.com/read/37351100/long-term-outcomes-from-the-uk-biobank-on-the-impact-of-coffee-on-cardiovascular-disease-arrhythmias-and-mortality-does-the-future-hold-coffee-prescriptions
#28
JOURNAL ARTICLE
Kotit Susy
INTRODUCTION: Coffee is a popular beverage and the most used psychostimulant worldwide. Habitual coffee consumption has been linked to a growing list of health benefits; however, coffee consumption has been a source of longstanding debate. Recent observational studies have challenged the misconception of caffeine and reported the safety and beneficial effects of coffee intake on a range of cardiovascular (CV) conditions, including coronary artery disease, arrhythmias, heart failure, and stroke, leading to a decreased risk of CVD, all-cause and CVD mortality, and being associated with favorable CV outcomes...
May 11, 2023: Global Cardiology Science & Practice
https://read.qxmd.com/read/37351099/delayed-presentation-of-biopsy-proven-eosinophilic-myocarditis-following-covid-19-mrna-vaccine
#29
Chaitra Janga, Tirth Patel, Hussam Al Hennawi, Sarin Atam, Shreeja Shah, Ifrah Naeem, Rahat Memon, Donald C Haas
Myopericarditis associated with COVID-19 mRNA vaccines has been recognized as an uncommon adverse reaction, especially among young, healthy adult males. Eosinophilic myocarditis is a rare form of inflammation reflecting a hypersensitivity reaction following an inciting event commonly caused by drugs including vaccines. Eosinophilic myocarditis, a subtype of myocarditis, is characterized by eosinophilic myocardial infiltrates. It is usually accompanied by systemic eosinophilia in the form of a drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome and is rarely associated with myocyte fibrosis and/or necrosis...
May 11, 2023: Global Cardiology Science & Practice
https://read.qxmd.com/read/37351098/lessons-from-a-pre-specified-meta-analysis-of%C3%A2-sodium-glucose-cotransporter-2-sglt2-inhibitors-in-heart-failure-time-for-new-clinical-recommendations
#30
JOURNAL ARTICLE
Susy Kotit
INTRODUCTION: Cardiovascular disease remains the leading cause of death worldwide with heart failure (HF) being one of the significant contributors to morbidity and mortality. The incidence of HF with preserved ejection fraction (HFpEF) is increasing, especially in young adults making it a growing public health matter. Sodium-glucose cotransporter-2 (SGLT2) inhibitors have been shown to reduce the development, progression, and mortality of heart failure in patients with reduced EF regardless of patients' diabetes status but their clinical benefits in patients with heart failure and preserved ejection fraction are less well-established...
May 11, 2023: Global Cardiology Science & Practice
https://read.qxmd.com/read/37351097/prevalence-of-coronary-artery-calcification-in-a-multiethnic-population-in-angola
#31
JOURNAL ARTICLE
Humberto Morais, Preciosa Lourenço, Carlos Martins, Lorette Cardona, Mauer A A Gonçalves
UNLABELLED: This article aims to study the prevalence of coronary artery calcification and associated factors in a multiethnic population in Angola. METHODS: A descriptive, cross-sectional observational study was carried out in a private clinic in Angola. For this purpose, information was collected from sociodemographic and biological data. The selected variables were; history of arterial hypertension, diabetes mellitus, smoking (current and past), alcohol consumption, family history of coronary disease, and coronary calcium score...
May 11, 2023: Global Cardiology Science & Practice
https://read.qxmd.com/read/37351096/when-images-don-t-explain-reality-a-case-of-an-intravascular-extension-of-an-endometrial-tumor
#32
Kyle Marrache, Hussam Al Hennawi, Shayan Qadir, Angad Bedi, Kevin Ye Hou
Endometrial stromal sarcoma is a rare mesenchymal tumor with the potential for intravascular metastases. We present the case of a 52-year-old female patient with a history of previously resected endometrial sarcoma who was found to have an inferior vena cava thrombus with intracardiac extension. Pathological assessment following resection revealed intravascular extension of an underlying endometrial stromal sarcoma. This case demonstrates the aggressive nature and intracardiac metastatic potential of endometrial sarcomas...
May 11, 2023: Global Cardiology Science & Practice
https://read.qxmd.com/read/37351095/role-of-hypoxia-inducible-factor-hif-1-%C3%AE-in-heart-valves
#33
REVIEW
Mark Georgy, Kareem Salhiyyah, Magdi H Yacoub, Adrian H Chester
The 2016 Albert Lasker Basic Medical Research Award and subsequently the 2019 Nobel Prize in Physiology or Medicine were awarded to William Kaelin, Jr., Sir Peter Ratcliffe, and Gregg Semenza for their work on how cells sense and adapt to hypoxic conditions. Their work showed that the changes in gene expression, cell metabolism, and tissue remodelling that occur in response to low oxygen concentrations are orchestrated by the transcription factor, hypoxia inducible factor-1 α (HIF-1 α ). While the effects mediated by HIF-1 α have been widely studied, its role in heart valves has only recently been investigated...
May 11, 2023: Global Cardiology Science & Practice
https://read.qxmd.com/read/37928601/lessons-from-the-first-in-human-in-vivo-crispr-cas9-editing-of-the-ttr-gene-by-ntla-2001-trial-in-patients-with-transthyretin-amyloidosis-with-cardiomyopathy
#34
JOURNAL ARTICLE
Susy Kotit
Introduction: Transthyretin amyloidosis (ATTR amyloidosis) is a progressive fatal disease characterized by accumulation of amyloid fibrils composed of misfolded transthyretin (TTR) protein in tissues, resulting in cardiomyopathy and heart failure. Approximately 50,000 people have hereditary ATTR amyloidosis, and up to 500,000 have wild-type ATTR amyloidosis globally, leading to poor quality of life and high morbidity, resulting in death within a median of 2 to 6 years after diagnosis. However, data on the prevalence of ATTR-CM is limited and poorly characterized...
January 30, 2023: Global Cardiology Science & Practice
https://read.qxmd.com/read/36890845/emmy-the-continued-expansion-of-clinical-applications-of-sglt2-inhibitors
#35
JOURNAL ARTICLE
Susy Kotit
Introduction: Myocardial infarction (MI) is a challenging clinical and public health problem and is a leading cause of morbidity and mortality worldwide. Heart failure (HF) is a common sequela of acute myocardial infarction (AMI), with an incidence of up to 40% among hospitalized patients and has important implications for treatment and prognosis. Sodium-glucose co-transporter 2 inhibitors (SGLT2i), such as empagliflozin, have been shown to reduce the risk of hospitalization and cardiovascular mortality in patients with symptomatic HF and have therefore been included in the European and American heart failure guidelines...
January 30, 2023: Global Cardiology Science & Practice
https://read.qxmd.com/read/36890844/minoca-mimic-type-2-myocardial-infarction-due-to-severe-aortic-stenosis-complicated-by-cardiogenic-shock
#36
Momin Islam, Hussam Al Hennawi, Mohamad Bakir, Anwar Khedr, Sachin S Goel
Acute myocardial infarction without significant obstructive coronary disease presents a challenging clinical entity that requires timely intervention. The term myocardial infarction with nonobstructive coronary arteries (MINOCA) describes a working diagnosis attributed to varying etiologies in patients with a presumed ischemic cardiac condition. Several overlapping etiologies can be classified as type 2 myocardial infarction (MI). The 2019 AHA statement established diagnostic criteria and clarified the associated confusion, aiding in appropriate diagnosis...
January 30, 2023: Global Cardiology Science & Practice
https://read.qxmd.com/read/36890843/invictus-vitamin-k-antagonists-remain-the-standard-of-care-for-rheumatic-heart-disease-associated-atrial-fibrillation
#37
JOURNAL ARTICLE
Susy Kotit
INTRODUCTION: Rheumatic heart disease (RHD) remains a major healthcare problem. Atrial fibrillation (AF) is the commonest sustained arrhythmia in RHD, leading to major complications and morbidity in a young population. Currently, anticoagulation with vitamin K antagonists (VKA) is the mainstay of therapy for the prevention of thromboembolic adverse events. However, effective use of VKA remains challenging, especially in developing countries, showing a need for alternatives. Novel oral anticoagulants (NOACs), including rivaroxaban, could form a safe and effective alternative to fulfil a major unmet need in RHD patients with AF...
January 30, 2023: Global Cardiology Science & Practice
https://read.qxmd.com/read/36890842/the-vicious-cycle-of-brash-syndrome-a-case-report
#38
Twinkle Saini, Jacky Reny, Hussam Al Hennawi, Andrew Cox, Chaitra Janga, Danila DeLiana, James McCaffrey
First described in 2016, BRASH syndrome is an underreported clinical entity characterized by bradycardia, renal dysfunction, atrioventricular nodal blockade (AVNB), shock, and hyperkalemia. The recognition of BRASH syndrome as a clinical entity is crucial for early and effective management. Patients with BRASH syndrome present with symptomatic bradycardia that is resistant to treatment with standard agents such as atropine. In this report, we present the case of a 67-year-old male patient who presented with symptomatic bradycardia with an ultimate diagnosis of BRASH syndrome...
January 30, 2023: Global Cardiology Science & Practice
https://read.qxmd.com/read/36890841/molecular-autopsy-in-sudden-cardiac-death
#39
REVIEW
Oscar Campuzano, Georgia Sarquella-Brugada
A post-mortem genetic analysis in the process of investigating a sudden death episode is known as 'molecular autopsy'. It is usually performed in cases without a conclusive cause of death and after a comprehensive medico-legal autopsy. In these sudden unexplained death cases, an underlying inherited arrhythmogenic cardiac disease is the main suspected cause of death. The objective is to unravel a genetic diagnosis of the victim, but it also enables cascade genetic screening of the victim's relatives. Early identification of a deleterious genetic alteration associated with an inherited arrhythmogenic disease may help to adopt preventive personalized measures to reduce risk of malignant arrhythmias and sudden death...
January 30, 2023: Global Cardiology Science & Practice
https://read.qxmd.com/read/36890840/chagas-disease-induced-ventricular-tachycardia-a-case-report
#40
Zaineb Alhassani, Hussam Al Hennawi, Prerana Sevella, Carolina Severiche Mena, Kathleen Coppola
Chagas disease is a protozoal infection caused by Trypanosoma cruzi ( T. cruzi ) that can affect many organ systems. Chagas cardiomyopathy tends to affect 30% of infected individuals. Cardiac manifestations include myocardial fibrosis, conduction defects, cardiomyopathy, ventricular tachycardia, and sudden cardiac death. In this report, we discuss a 51-year-old male who presented with recurrent episodes of non-sustained ventricular tachycardia refractory to medical therapy.
January 30, 2023: Global Cardiology Science & Practice
journal
journal
48227
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.